WHO confirms the trial of anti-Malaria drug Hydroxychloroquine

WHO confirms the trial of anti-Malaria drug Hydroxychloroquine: The World Health Organization (WHO) has announced to resume the trials for anti-malaria drug Hydroxychloroquine for its effectiveness against the novel coronavirus.

Comments

Popular posts from this blog

Eurotech has carved its niche to address Networking and Communications requirements.

DCIM gaining momentum with growth of data centers

CLOUD COMPUTING : Nitin Hiranandani, Director, HP India